Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Giachetti

Showing results (121-130 of 156) with videos related to

Pageof 16
Sort By:
European Journal of Pharmacology|July 4, 1989
The C-terminal hexapeptide, endothelin-(16-21), discriminates between different endothelin receptorsC A Maggi, S Giuliani, R Patacchini, et al.
British Journal of Pharmacology|November 1, 1989
Multiple sources of calcium for contraction of the human urinary bladder muscleC A Maggi, S Giuliani, R Patacchini, et al.
Endocrinology|July 1, 1979
On the role of the central serotoninergic system in the regulation of the secretion of thyrotropin and prolactin: thyrotropin-inhibiting and prolactin-releasing effects of 5-hydroxytryptamine and quipazine in the male ratL Krulich, E Vijayan, R J Coppings, et al.
European Journal of Pharmacology|October 22, 1991
NK2 tachykinin receptors and contraction of circular muscle of the human colon: characterization of the NK2 receptor subtypeS Giuliani, G Barbanti, D Turini, et al.
Journal of Autonomic Pharmacology|August 1, 1991
Effect of synthetic tachykinin analogues on airway microvascular leakage in rats and guinea-pigs: evidence for the involvement of NK-1 receptorsL Abelli, C A Maggi, P Rovero, et al.
Oxidative Medicine and Cellular Longevity|December 13, 2018
ALDH2 Activity Reduces Mitochondrial Oxygen Reserve Capacity in Endothelial Cells and Induces Senescence PropertiesG Nannelli, E Terzuoli, V Giorgio, et al.
Arzneimittel-Forschung|January 1, 1985
Cimetropium: characterization of antimuscarinic and spasmolytic propertiesA Schiavone, G B Schiavi, L De Conti, et al.
Neuropeptides|June 1, 1992
Interaction of amyloid beta protein (25-35) with tachykinin receptorsP Rovero, R Patacchini, A R Renzetti, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1993
Characterization of the tachykinin neurokinin-2 receptor in the human urinary bladder by means of selective receptor antagonists and peptidase inhibitorsS Giuliani, R Patacchini, G Barbanti, et al.
Peptides|May 1, 1989
A potent and selective agonist for NK-2 tachykinin receptorP Rovero, V Pestellini, R Patacchini, et al.
Pageof 16

Showing results (121-130 of 156) with videos related to

Sort By:
Pageof 16
European Journal of Pharmacology|July 4, 1989
The C-terminal hexapeptide, endothelin-(16-21), discriminates between different endothelin receptorsC A Maggi, S Giuliani, R Patacchini, et al.
British Journal of Pharmacology|November 1, 1989
Multiple sources of calcium for contraction of the human urinary bladder muscleC A Maggi, S Giuliani, R Patacchini, et al.
Endocrinology|July 1, 1979
On the role of the central serotoninergic system in the regulation of the secretion of thyrotropin and prolactin: thyrotropin-inhibiting and prolactin-releasing effects of 5-hydroxytryptamine and quipazine in the male ratL Krulich, E Vijayan, R J Coppings, et al.
European Journal of Pharmacology|October 22, 1991
NK2 tachykinin receptors and contraction of circular muscle of the human colon: characterization of the NK2 receptor subtypeS Giuliani, G Barbanti, D Turini, et al.
Journal of Autonomic Pharmacology|August 1, 1991
Effect of synthetic tachykinin analogues on airway microvascular leakage in rats and guinea-pigs: evidence for the involvement of NK-1 receptorsL Abelli, C A Maggi, P Rovero, et al.
Oxidative Medicine and Cellular Longevity|December 13, 2018
ALDH2 Activity Reduces Mitochondrial Oxygen Reserve Capacity in Endothelial Cells and Induces Senescence PropertiesG Nannelli, E Terzuoli, V Giorgio, et al.
Arzneimittel-Forschung|January 1, 1985
Cimetropium: characterization of antimuscarinic and spasmolytic propertiesA Schiavone, G B Schiavi, L De Conti, et al.
Neuropeptides|June 1, 1992
Interaction of amyloid beta protein (25-35) with tachykinin receptorsP Rovero, R Patacchini, A R Renzetti, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1993
Characterization of the tachykinin neurokinin-2 receptor in the human urinary bladder by means of selective receptor antagonists and peptidase inhibitorsS Giuliani, R Patacchini, G Barbanti, et al.
Peptides|May 1, 1989
A potent and selective agonist for NK-2 tachykinin receptorP Rovero, V Pestellini, R Patacchini, et al.
Pageof 16